Drug Search Results
More Filters [+]

Poliglecaprone

Alternative Names: poliglecaprone
Latest Update: 2024-08-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Colombia | Dominican Republic

Approved Indications: None

Known Adverse Events: None

Company: Dr. Tony Cheung
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Poliglecaprone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Cesarean Section|Surgical Wound Infection|Oncology Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AA-2024-3

N/A

Not yet recruiting

Surgical Wound Infection|Cesarean Section|Obesity

2025-07-31

STU 2021-0791

N/A

Active, not recruiting

Injuries/wounds Unspecified

2024-04-04

NCT02459093

P4

Completed

Cesarean Section|Surgical Wound Infection

2016-07-01

LAP-APR-2012-028

P4

Completed

Oncology Unspecified

2013-12-01

Recent News Events